2m 2m 2m 2m 2m 2m 2m
NIKA PHARMA (NIKA)
OTC
$0.44+$0.24 (+119.80%)
Price as of Jun 24, 2026- $465.6MMarket Cap
- -35.65%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
NIKA PHARMA (NIKA)
$0.44+$0.24 (+119.80%)
NIKA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.44 | ||
Change | +$0.24 (+119.80%) | ||
Open | $0.51 | ||
High | $0.51 | ||
Low | $0.44 | ||
Previous Close | $0.20 | ||
Volume | 900 | ||
30-Day Average Volume | 798 | ||
1-Week Change | -12.91% | ||
1-Month Change | -12.94% | ||
1-Year Change | -35.65% | ||
3-Year Change | -23.05% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.0B | ||
Total Assets | $20,637.00 | ||
Market Cap | $465.6M | ||
Enterprise Value | $465.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$13,359.00 | ||
Free Cash Flow | -$13,359.00 | ||
EBIT | -$13,359.00 | ||
EBITDA | -$13,359.00 | ||
Net Working Capital | -$310,987.00 | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -34,874 | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -34,850 | ||
Price/Operating Cash Flow | -34,850 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue